Patents by Inventor Matthew Kaser

Matthew Kaser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230062872
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: February 9, 2022
    Publication date: March 2, 2023
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • Patent number: 11278506
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: March 22, 2022
    Assignee: RB HEALTH (US) LLC
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • Publication number: 20170100355
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 13, 2017
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • Publication number: 20140020711
    Abstract: Peroxygen containing cleaning substrates, such as wipes and sponges which exhibit improved storage stability, and in preferred embodiments, also exhibit an antimicrobial benefit to hard surfaces treated with the peroxygen containing cleaning substrates.
    Type: Application
    Filed: March 9, 2012
    Publication date: January 23, 2014
    Applicant: Reckitt Benckiser LLC
    Inventor: Matthew Kaser
  • Publication number: 20070054312
    Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.
    Type: Application
    Filed: November 8, 2006
    Publication date: March 8, 2007
    Inventors: Y. Tang, Preeti Lal, Jennifer Hillman, Henry Yue, Karl Guegler, Neil Corley, Olga Bandman, Chandra Patterson, Gina Gorgone, Matthew Kaser, Mariah Baughn, Janice Au-Young
  • Patent number: 5981263
    Abstract: The invention provides a human matrilin-3 (MAT-3) and polynucleotides which identify and encode MAT-3. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of MAT-3.
    Type: Grant
    Filed: July 21, 1997
    Date of Patent: November 9, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah, Matthew Kaser
  • Patent number: D747791
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: January 19, 2016
    Assignee: RECKITT BENCKISER LLC
    Inventors: Matthew Kaser, Raghu Cavatur, Nils Ahlgren